Skip to main content

Month: March 2022

Xtant Medical to Present at the Canaccord Musculoskeletal Conference on March 22, 2022

BELGRADE, Mont., March 15, 2022 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, President and Chief Executive Officer, will present at the Canaccord Musculoskeletal Conference on Tuesday, March 22, 2022, at 2:00 p.m. Central Time in Chicago. A live webcast of the presentation will be available on the Investors section of the Company’s website or through the conference site by using the link below: Date: Tuesday, March 22, 2022Time: 2:00 p.m. CT / 3:00 p.m. ETWebcast: Click Here A replay of the webcast will be available for approximately 90 days on the Company’s website at www.xtantmedical.com following the conclusion of the presentation. About Xtant Medical Holdings, Inc. Xtant...

Continue reading

GBT Filed a Non-Provisional Patent – AI Empowered, Long-Range, Radio system

The patent seeks to provide comprehensive IP protection for intelligent, long range radio technology, including architecture, concepts, and methods SAN DIEGO, March 15, 2022 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT” or the “Company”), filed a non-provisional patent, application #17686461, for its long range, intelligent radio system, which has been assigned an internal code name Infinia. The patent seeks to protect a long-range data and voice communication system, that is operating via High Frequency (HF) radio waves. The technology intends to communicate through an ionospheric propagation environment to reach very long distances. The design incorporates AI systems and methods to overcome long range HF radio major challenges including skip zones, where there is no reception. The proposed dead-zone solution...

Continue reading

Caladrius Biosciences to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on Tuesday, March 22, 2022, at 4:30 p.m. Eastern Time

BASKING RIDGE, N.J., March 15, 2022 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of innovative therapies designed to treat or reverse disease, today announced that the Company will report its financial results for the three months and twelve months ended December 31, 2021, on Tuesday, March 22, 2022, at 4:30 p.m. (ET). To join the live conference call, please refer to the dial-in information provided below. Dial-in information: Conference ID: 5066195U.S. Toll-Free: 866-595-8403International: 706-758-9979 Please dial-in 10 minutes before the start of the conference call. A live webcast of the call will also be accessible under the Investors & News section of the Caladrius website (https://ir.caladrius.com)...

Continue reading

Lightbridge CEO Seth Grae to Participate in Panel Discussion at SXSW 2022

Panel to Discuss “Fueling the Future Food System; People, Power & Purpose” RESTON, Va., March 15, 2022 (GLOBE NEWSWIRE) — Lightbridge Corporation (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced that President and CEO Seth Grae will participate in a panel at SXSW called “Fueling the Future Food System; People, Power & Purpose” on Friday, March 18 at 11:40 am CT (12:40 pm ET). The panel will be moderated by Dr. Sweta Chakraborty, President of We Don’t Have Time U.S., and an Independent Director and Chair of the ESG Committee of the Board of Lightbridge. Mr. Grae will also participate in investor meetings throughout the event. The panel is part of Future of Food, an official SXSW event spanning two full days of programming on March 17 and 18 at the SXSW Center. The event will bring together a diverse...

Continue reading

Asia Broadband Prepares For Imminent Launch of Mobile App Versions of Proprietary Cryptocurrency Exchange

LAS VEGAS, March 15, 2022 (GLOBE NEWSWIRE) — Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company is anticipating the launch of its AABB Exchange mobile applications on the Apple and Android stores before March 22, 2022. The Company’s digital assets developer is currently finalizing the mobile versions of the proprietary cryptocurrency Exchange to submit for approval. The Exchange will soon be available to users on their mobile phones to place buy and sell orders to execute cryptocurrency trades for an expanding number of trading pairs available on the Exchange platform. Currently, users can access the Desktop version of the AABB Exchange by going to: https://aabbexchange.com/trade/ then on the right side of the monitor, click on “Log In or Register Now to trade”. Once you...

Continue reading

Alector Presents AL001 (latozinemab) Data from the FTD-C9orf72 Cohort of the INFRONT-2 Phase 2 Clinical Trial

Treatment with AL001 (latozinemab) demonstrated target engagement and resulted in increases in progranulin levels in all patients FTD-C9orf72 patients treated with latozinemab demonstrated a trend toward a delay in disease progression relative to the ALLFTD matched control cohort First clinical dataset in an indication where latozinemab elevated progranulin above physiological levels Company to host webcast to review results today at 8:30 a.m. ET SOUTH SAN FRANCISCO, Calif., March 15, 2022 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, presented results from the INFRONT-2 Phase 2 clinical trial of AL001 (latozinemab) in frontotemporal dementia patients (FTD) with a C9orf72 genetic mutation (FTD-C9orf72) at the AD/PD™ 2022 International Conference on Alzheimer’s...

Continue reading

Springs Rejuvenation Inc. Establishes Partnership with American Top Team Company

SPRJ Trainer George Mathews, Owner/head coach Roan “Jucao” Carneiro and Dr Charles PereyraAtlanta, GA, March 15, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Springs Rejuvenation Inc. (OTC: SPRJ), announced a partnership with American Top Team, a leading gym for MMA, BJJ and Fitness Training, by providing stem cell therapies and treatments to their members and competitive athletes.  Dr Charles Pereyra, Springs Rejuvenation Founder and Chief Operating Officer, stated, “I am excited for the opportunity to partner with American Top Team which is one of the world’s premier facilities for training elite combat athletes, including both UFC and Bellator Champions. I’ve personally been involved in mix martial arts and competition for many years, and I am familiar with the injuries, treatments and therapies needed to...

Continue reading

Wee-Cig, EZ365 CEO Russell Korus to Share Industry Leading Expertise on NFTs at the 2022 Artificial Intelligence and Blockchain UAE Expo in Dubai

Korus will educate participating investors and enhance public understanding of NFTs and their incredible potential Las Vegas, NV, March 15, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Wee-Cig International Corporation (OTCMarkets: WCIG), a company focused on identifying and growing top tech companies in emerging markets, today announced that CEO and Founder of operating subsidiary dba, “EZ365”, Russell Korus, will be a featured speaker at the upcoming Artificial Intelligence and Blockchain (AIBC) 2022 UAE Expo in Dubai March 20 through 23. In his dynamic presentation “NFTs: What Are They and Why Should You Care?” Korus will educate and inspire new entrants to the world of blockchain-based digital assets, especially those considering investing in NFTs. “Anyone looking to participate in the excitement and opportunity of the...

Continue reading

Mersana Therapeutics to Present an Analysis from the Expansion Cohort of the Phase 1 Trial of Upifitamab Rilsodotin at the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer

CAMBRIDGE, Mass., March 15, 2022 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that it will present an analysis based on the June 10th, 2021 data cut from the expansion cohort of the Company’s Phase 1 trial of upifitamab rilsodotin (UpRi) at the upcoming Society of Gynecologic Oncology Annual Meeting on Women’s Cancer being held from March 18-21, 2022 in Phoenix, Arizona. UpRi is a Dolaflexin ADC targeting NaPi2b and is being studied in UPLIFT, a single-arm registrational trial in patients with platinum-resistant ovarian cancer, as well as in UPGRADE, a Phase 1/2 umbrella trial evaluating UpRi in combinations starting...

Continue reading

Reservoir Announces Publishing Deal With Grammy-Winning Artist and Songwriter Killer Mike

NEW YORK, March 15, 2022 (GLOBE NEWSWIRE) — Reservoir Media, Inc. (NASDAQ: RSVR) (“Reservoir” or the “Company”), an award-winning independent music company, today announced a global publishing deal with Grammy-winning artist and songwriter Michael Render aka Killer Mike, who is part of the popular hip-hop super duo, Run The Jewels. The deal includes his entire catalog and future works.  The Atlanta-born Mike has released four studio albums alongside his Run The Jewels partner, EL-P. Their most recent, RTJ4, soared to the Top 10 on the Billboard 200 and was met with widespread critical acclaim, landing at #1 on NME’s The Best 50 Albums of 2020 list. Named the 2020 Spin Magazine Artist of the Year, Run The Jewels have won eleven Libera Awards, including the 2021 A2IM Humanitarian Award, took home four Clio Awards, including two Gold-winning...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.